FEI Tribunal issues Consent Award in equine anti-doping case

The FEI Tribunal has issued a Consent Award in an equine anti-doping case involving a Banned Substance.

In this case, the horse Meadowvale Cruise (FEI ID 106CQ68/USA), tested positive for the Banned Substance Testosterone following samples taken at the Bolivarian Games-S - Bogotá (COL), 24.06. – 05.07.2022.

The athlete, Hector Florentino Roca (FEI ID 10009161/DOM), admitted the rule violation and accepted the consequences. In its final decision the FEI Tribunal disqualified the horse from the event and imposed an eighteen-month ineligibility period on the athlete; the provisional suspension he already served shall be credited against the imposed ineligibility period. He was also fined CHF 5,000 and asked to cover the costs of the B sample, CHF 1,000.

The full Decision is available here.

Separately, the FEI has announced new adverse analytical findings (AAF) involving equine prohibited substances. The cases involve a *Banned Substance and a Controlled Medication Substance under the FEI’s Equine Anti-Doping and Controlled Medication Regulations (EADCMRs).
In these two Jumping cases, the athletes have not been provisionally suspended. The horses have been provisionally suspended for two months from the date of notification.

Case 2022/BS10:

Horse: Blanch (107VD44/LTU)
Person Responsible: Nerijus Sipaila (10044738/LTU)
Event: CSIYH1*- Kunkiai (LTU), 25-28.08.2022,
Prohibited Substance(s): Morphine, Oripavine
Date of notification: 22 December 2022

Case 2022/BS04:

Horse: Cindy NSO (107XY33/LTU)
Person Responsible: Vilte Kasiulyte (10129107/LTU)
Event: CSIYH1*- Vazgaikiemis (LTU), 01-04.09.22,
Prohibited Substance(s): Morphine, Oripavine
Date of notification: 22 December 2022

Details on these cases can be found here.

Article courtesy of FEI